Trial Site Detail

 

Drug:
CB-839 + Talazoparib
Trial:
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
Conditions: Solid Tumors
Trial Status:
Terminated

 

Emory Winship Cancer Institute

1365C Clifton Road     
Atlanta , GA 30322
USA

 

Principal Investigator:
Manali Bhavi, MD
Contact:
Manali Bhavi, MD 404-778-1900 manali.ajay.bhave@emory.edu
Activation Status of this Site:
Closed
Notes about this Site:
Emory Winship Cancer Institute Website:
http://cancer.emory.edu/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.